Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1
Abstract
Insulin-like growth factor (IGF) 1 is a member of a family that is involved in growth, development, cell differentiation, and metabolism. IGF1, IGF2 and insulin act primarily through tyrosine-kinase-linked receptors--the IGF1 receptor (IGF1R) and insulin receptor (IR). The IGF1R binds IGF1 and IGF2 with high affinity and the IR binds insulin with high affinity; however, since both receptors share a high degree of structural and functional homology, the IGF1R can bind insulin and the IR can bind the IGFs with reduced affinity. These two receptors can, moreover, form heterodimers, which bind both ligands. Upon binding to the receptors, cascades of tyrosine and serine kinases are stimulated to facilitate growth or metabolism. The IGF2 receptor is a scavenger receptor, and is, therefore, not involved in mediation of growth or metabolic effects of the IGF family and will not be discussed in the current article. IGF1 is a major gene target of growth hormone and its product mediates many of the actions of growth hormone on growth and development; however, IGF1 has actions distinct from those of growth hormone in carbohydrate, lipid, and protein metabolism. For example, excess growth hormone causes insulin resistance and hyperglycemia, whereas IGF1 has insulin-like effects that reduce blood glucose levels and has been used experimentally to treat both type 1 and type 2 diabetes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The effects of growth hormones on glucose regulation is intricate.
“The effects of growth hormones on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
The effect of growth hormone on glucose regulation is intricate and changes substantially with different dosage and treatment duration.
“on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
The effects of growth hormones on glucose regulation changes substantially with different dosage and treatment duration.
“The effects of growth hormones on glucose regulation is intricate and changes substantially with different dosage and treatment duration (49, 51).”
From The progression of secondary diabetes: A review of modeling studies (2022) · cites this paper as [49]
Growth hormone in contrast to IGF-1 has many catabolic effects leading to provision of energy-rich substrates to an activated immune system in inflammation.
“Thus, growth hormone in contrast to IGF-1 has many catabolic effects leading to provision of energy-rich substrates to an activated immune system in inflammation.”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [57]
Cites
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Firth, S. M., & Baxter, R. C. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0033 · Cited by 1,754 · see citing works
Effects of Human Growth Hormone in Men over 60 Years Old
Rudman, D. R., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,551 · see citing works
Normal growth and development in the absence of hepatic insulin-like growth factor I
Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418 · see citing works
Self-citationIncreased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023 · see citing works
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889 · see citing works
Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.
Bengtsson, B. Å., Edén, S., Lönn, L., Kvist, H., Stokland, A. M., Lindstedt, G., Bosaeus, I. G., Tölli, J., Sjöström, L., & Isaksson, O. G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432773 · Cited by 780 · see citing works
Roles of Growth Hormone and Insulin-like Growth Factor 1 in Mouse Postnatal Growth
Lupu, F. I., Terwilliger, J. D., Lee, K., Segre, G. V., & Efstratiadis, A. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9975 · Cited by 769 · see citing works
Fat cell adrenergic receptors and the control of white and brown fat cell function
Lafontan, M., & Berlan, M. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37695-1 · Cited by 636 · see citing works
Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice <sup>1</sup>
Coschigano, K. T., Clemmons, D., Bellush, L. L., & Kopchick, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.7.7586 · Cited by 611 · see citing works
Targeted Disruption of the β3-Adrenergic Receptor Gene
Susulic, V. S., Frederich, R. C., Lawitts, J. A., Tozzo, E., Kahn, B. B., Harper, M., Himms‐Hagen, J., Flier, J. S., & Lowell, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29483 · Cited by 493 · see citing works
EFFECT OF GROWTH HORMONE ON PLASMA FATTY ACIDS*
Raben, M. S., & Hollenberg, C. H. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103824 · Cited by 448 · see citing works
Biolo, G., Declan Fleming, R. Y., & Wolfe, R. R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117731 · Cited by 442 · see citing works
Human growth hormone prevents the protein catabolic side effects of prednisone in humans.
Horber, F., & Haymond, M. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114694 · Cited by 405 · see citing works
Liver-Specific igf-1 Gene Deletion Leads to Muscle Insulin Insensitivity
Yakar, S., Liu, J., Fernandez, A. M., Wu, Y., Schally, A. V., Frystyk, J., Chernausek, S. D., Mejía, W., & Roith, D. L. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1110 · Cited by 343 · see citing works
Self-citationJohannsson, G., Mårin, P., Lönn, L., Ottosson, M., Stenlöf, K., Björntorp, P. A., Sjöström, L., & Bengtsson, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3809 · Cited by 336 · see citing works
Effect of Growth Hormone Treatment on the Adult Height of Children with Chronic Renal Failure
Haffner, D., Schaefer, F. S., Nissel, R., Wühl, E., Tönshoff, B., & Mehls, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431304 · Cited by 301 · see citing works
Moses, A. C., Young, S. C., Morrow, L. A., O'Brien, M., & Clemmons, D. R. (1996) · Diabetes · doi:10.2337/diab.45.1.91 · Cited by 291 · cited 1× · see citing works
“In patients with severe type A (genetically induced) insulin resistance, rhIGF1 leads to a reduction in serum glucose and insulin and improved insulin sensitivity”
BackgroundImportance of growth hormone for the induction of hepatic low density lipoprotein receptors.
Rudling, M. J., Norstedt, G., Olivecrona, H., Reihnér, E., Gustafsson, J.-Α., & Angelin, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6983 · Cited by 269 · see citing works
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Yakar, S., Setser, J., Zhao, H., STANNARD, B. S., Haluzı́k, M., Glatt, V., Bouxsein, M., Kopchick, J. J., & LeRoith, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci17763 · Cited by 249 · see citing works
Self-citationLiu, J., Coschigano, K. T., Robertson, K., Lipsett, M. A., Guo, Y., Kopchick, J. J., Kumar, U., & Liu, Y. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00423.2003 · Cited by 218 · see citing works
Dupont, J., & LeRoith, D. (2001) · Hormone Research in Paediatrics · doi:10.1159/000063469 · Cited by 217 · see citing works
Self-citationThe relative roles of growth hormone and IGF-1 in controlling insulin sensitivity
Clemmons, D. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20660 · Cited by 202 · see citing works
Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1–deficient mice
Yakar, S., Setser, J., Zhao, H., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200417763 · Cited by 201 · see citing works
Self-citationImportance of Raised Growth Hormone Levels in Mediating the Metabolic Derangements of Diabetes
Press, M., Tamborlane, W. V., & Sherwin, R. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403293101302 · Cited by 198 · see citing works
Jørgensen, J. O. L., Thuesen, L., Müller, J., Ovesen, P., Skakkebæk, N. E., & Christiansen, J. S. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300224 · Cited by 179 · see citing works
Hussain, M. A., Schmitz, O., Mengel, A., Keller, A., Christiansen, J. S., Zapf, J., & Froesch, E. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116828 · Cited by 170 · see citing works
Insulin sensitivity of protein and glucose metabolism in human forearm skeletal muscle
Louard, R. J., Fryburg, D. A., Gelfand, R. A., & Barrett, E. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116124 · Cited by 169 · see citing works
Scavo, L. M., Karas, M., Murray, M., & LeRoith, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031682 · Cited by 157 · see citing works
Self-citationHypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors.
Cola, G. D., Cool, M. H., & Accili, D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119438 · Cited by 156 · see citing works
Franco, C., Brandberg, J., Lönn, L., Andersson, B., Bengtsson, B., & Johannsson, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1657 · Cited by 151 · see citing works
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
Zenobi, P. D., Graf, S., Ursprung, H., & Froesch, E. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115796 · Cited by 135 · see citing works
Turkalj, I., Keller, U. B., Ninnis, R., Vosmeer, S., & Stauffacher, W. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.5.1430077 · Cited by 133 · see citing works
Are the metabolic effects of GH and IGF-I separable?
Mauras, N., & Haymond, M. W. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.12.003 · Cited by 131 · see citing works
Clemmons, D. R., Moses, A. C., McKay, M. J., Sommer, A., Rosen, D. M., & Ruckle, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6559 · Cited by 128 · see citing works
GROWTH HORMONE AND THE METABOLISM OF CARBOHYDRATE AND LIPID IN ADIPOSE TISSUE*
GOODMAN, H. M. (1968) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1968.tb20367.x · Cited by 124 · see citing works
Mauras, N., O'Brien, K. O., Welch, S., Rini, A., Helgeson, K., Vieira, N. E., & Yergey, A. L. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6541 · Cited by 117 · see citing works
Dominici, F. P., Diaz, G. A., Bartke, A., Kopchick, J., & Turyn, D. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660579 · Cited by 116 · see citing works
Haluzı́k, M., Yakar, S., Gavrilova, O., Setser, J., Boisclair, Y. R., & LeRoith, D. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2483 · Cited by 116 · see citing works
Self-citationIGFs and IGFBPs: role in health and disease
Monzavi, R., & Cohen, P. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0212 · Cited by 115 · see citing works
Zick, Y. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320812 · Cited by 115 · see citing works
Frost, R. A., Fuhrer, J., Steigbigel, R. T., Mariuz, P., Lang, C. H., & Gelato, M. C. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.705526.x · Cited by 99 · see citing works
Action of Growth Hormone in Adipose Tissue
Richelsen, B. (1997) · Hormone Research · doi:10.1159/000191338 · Cited by 94 · see citing works
Growth hormone receptor antagonist improves insulin resistance in acromegaly
Rose, D. R., & Clemmons, D. R. (2002) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(02)00083-7 · Cited by 90 · see citing works
Morrow, L., O'Brien, M. B., Moller, D. E., Flier, J. S., & Moses, A. C. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027228 · Cited by 88 · see citing works
Kim, K. R., Nam, S. Y., Song, Y. D., Lim, S. K., Lee, H. C., & Huh, K. B. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023319 · Cited by 86 · see citing works
Insulin-like growth factor binding proteins as glucoregulators
Baxter, R. C. (1995) · Metabolism · doi:10.1016/0026-0495(95)90215-5 · Cited by 79 · see citing works
Mauras, N., George, D. E., Evans, J., Milov, D. E., Abrams, S. A., Rini, A., Welch, S., & Haymond, M. W. (2002) · Metabolism · doi:10.1053/meta.2002.28972 · Cited by 78 · see citing works
Nørrelund, H., Nair, K. S., Nielsen, S., Frystyk, J., Ivarsen, P., Jørgensen, J. O. L., Christiansen, J. S., & Møller, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030267 · Cited by 70 · see citing works
Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance
Ranke, M. B. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.03.011 · Cited by 62 · see citing works
Segerlantz, M., Bramnert, M., Manhem, P., Laurila, E., & Groop, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8096 · Cited by 61 · see citing works
Guo, Y., Lu, Y., Houle, D., Robertson, K., Tang, Z., Kopchick, J. J., Liu, Y. L., & Liu, J. (2005) · Endocrinology · doi:10.1210/en.2004-1203 · Cited by 60 · see citing works
Huang, Y., Kim, S.-O., Yang, N., Jiang, J., & Frank, S. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0418 · Cited by 59 · see citing works
Acerini, C. L., Harris, D. A., Matyka, K. A., Watts, A., Umpleby, A. M., Russell-Jones, D. L., & Dunger, D. B. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90074-9 · Cited by 53 · see citing works
Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting
Mulligan, K. M., & Schambelan, M. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00247-4 · Cited by 52 · see citing works
Albert, S. G., & Mooradian, A. D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031264 · Cited by 48 · see citing works
Oscarsson, J., Ottosson, M., Vikman, K., Frick, F., Enerbäck, S., Lithell, H., & Edén, S. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600247 · Cited by 47 · see citing works
Hollenga, C., Brouwer, F., & Zaagsma, J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12215.x · Cited by 43 · see citing works
Yuen, K. C. J., Ong, K. K., Husbands, S., Chatelain, P., Fryklund, L., Gluckman, P. D., Ranke, M. B., Cook, D. M., Rosenfeld, R. G., Wass, J. A. H., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8460 · Cited by 34 · see citing works
Mauras, N. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673406 · Cited by 31 · see citing works
Heffernan, M., Summers, R. J., Thorburn, A. W., Ogru, E., Gianello, R., Jiang, W., & Ng, F. M. (2001) · Endocrinology · doi:10.1210/endo.142.12.8522 · Cited by 31 · see citing works
Changes in IGF-I receptor and IGF-I mRNA during differentiation of 3T3-L1 preadipocytes
Zizola, C. F., Balañá, M. E., Sandoval, M., & Calvo, J. C. (2002) · Biochimie · doi:10.1016/s0300-9084(02)00009-3 · Cited by 28 · see citing works
Taaffe, D. R., Lewis, B., & Marcus, R. (1994) · Clinical Science · doi:10.1042/cs0870581 · Cited by 26 · see citing works
Yuen, K. C. J., Frystyk, J., Umpleby, A. M., Fryklund, L., & Dunger, D. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0300 · Cited by 26 · see citing works
Arslanian, S. A., Menon, R. K., Gierl, A. P., Heil, B. V., & Foley, T. P. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00175.x · Cited by 25 · see citing works
Use of Growth Hormone and Other Anabolic Agents in AIDS Wasting
Mulligan, K. M., Tai, V., & Schambelan, M. (1999) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719902300606 · Cited by 23 · see citing works
Clemmons, D. R. (2008) · Hormone Research · doi:10.1159/000183769 · Cited by 19 · see citing works
Taaffe, D. R., Thompson, J. L., Butterfield, G. E., Hoffman, A. R., & Marcus, R. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-14930 · Cited by 17 · see citing works
Clemmons, D. R., Sleevi, M., & Busby, W. H. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1389 · Cited by 14 · see citing works
Unterman, T. G. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2988-0_21 · Cited by 12 · see citing works
The use of growth hormone in severely ill patients.
Dw, W. (1999) · PubMed · Cited by 9 · see citing works
Physiological effects and potential applications of GH and IGF-I.
Da, F., & Ej, B. (1999) · PubMed · Cited by 3 · see citing works
Metabolic Effects of rhIGF-1 in Normal Human Subjects
Rennert, N. J., Boulware, S. D., Kerr, D. E., Caprio, S., Tamborlane, W. V., & Sherwin, R. S. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2988-0_30 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0087 · Cited by 1,009 · see citing works
Acromegaly pathogenesis and treatment
Melmed, S. K. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 690 · see citing works
Kumar, K. G., Trevaskis, J. L., Lam, D. D., Sutton, G. M., Koza, R. A., Chouljenko, V. N., Kousoulas, K. G., Rogers, P. M., Kesterson, R. A., Thearle, M. S., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.10.011 · Cited by 511 · see citing works
Inhibition of Growth Hormone Signaling by the Fasting-Induced Hormone FGF21
Inagaki, T., Lin, V. Y., Goetz, R., Mohammadi, M., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.006 · Cited by 409 · see citing works
Clemmons, D. R. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.150631 · Cited by 352 · see citing works
Insulin-like growth factor-1 deficiency and metabolic syndrome
Aguirre, G. A., Ita, J. R. D., de la Garza, R. G., & Castilla‐Cortázar, I. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-015-0762-z · Cited by 297 · see citing works
Brain IGF-1 Receptors Control Mammalian Growth and Lifespan through a Neuroendocrine Mechanism
Kappeler, L., Filho, C. D. D. M., Dupont, J., Leneuve, P., Cervera, P., Périn, L., Loudes, C., Blaise, A., Klein, R., Epelbaum, J., et al. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060254 · Cited by 289 · see citing works
Reversal of Type 1 Diabetes in Mice by Brown Adipose Tissue Transplant
Gunawardana, S. C., & Piston, D. W. (2012) · Diabetes · doi:10.2337/db11-0510 · Cited by 290 · see citing works
Adropin Deficiency Is Associated With Increased Adiposity and Insulin Resistance
Kumar, K. G., Zhang, J., Gao, S., Rossi, J., McGuinness, O. P., Halem, H. H., Culler, M. D., Mynatt, R. L., & Butler, A. A. (2012) · Obesity · doi:10.1038/oby.2012.31 · Cited by 262 · see citing works
Fan, Y., Menon, R. K., Cohen, P., Hwang, D., Clemens, T. L., DiGirolamo, D. J., Kopchick, J. J., Roith, D. L., Trucco, M., & Sperling, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014308 · Cited by 255 · see citing works
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Kasprzak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126434 · Cited by 248 · see citing works
O-Sullivan, I., Zhang, W., Wasserman, D. H., Liew, C. W., Liu, J., Paik, J., DePinho, R. A., Stolz, D. B., Kahn, C. R., Schwartz, M. W., et al. (2015) · Nature Communications · doi:10.1038/ncomms8079 · Cited by 228 · see citing works
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208 · see citing works
IGF-1R as an anti-cancer target--trials and tribulations
Chen, H. X., & Sharon, E. (2013) · 癌症:英文版 · doi:10.5732/cjc.012.10263 · Cited by 201 · see citing works
Annunziata, M., Granata, R., & Ghigo, E. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0227-z · Cited by 197 · see citing works
The current status of IGF-I assays – A 2009 update
Frystyk, J., Freda, P. U., & Clemmons, D. R. (2009) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2009.09.004 · Cited by 196 · see citing works
Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
Hellström, A., Ley, D., Pupp, I. H., Hallberg, B., Löfqvist, C., Marter, L. J. V., van Weissenbruch, M. M., Ramenghi, L. A., Beardsall, K., Dunger, D. B., et al. (2016) · Acta Paediatrica · doi:10.1111/apa.13350 · Cited by 190 · see citing works
Effects of growth hormone on glucose metabolism and insulin resistance in human
Kim, S.-H., & Park, M.-J. (2017) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2017.22.3.145 · Cited by 181 · see citing works
Li, C., Xing, C., Zhang, J., Zhao, H., Shi, W., & He, B. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02817-2 · Cited by 180 · see citing works
Signaling in Cell Differentiation and MorphogenesisPreprint
Basson, M. A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008151 · Cited by 176 · see citing works
Exercise and the Growth Hormone-Insulin-Like Growth Factor Axis
Frystyk, J. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181b07d2d · Cited by 171 · see citing works
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2015) · Nature Communications · doi:10.1038/ncomms8078 · Cited by 169 · see citing works
Boucher, J., Tseng, Y., & Kahn, C. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118620 · Cited by 163 · see citing works
Kleinberg, D. L., Wood, T. L., Furth, P. A., & Lee, A. V. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0022 · Cited by 162 · see citing works
In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
Sommerfeld, M. R., Müller, G. A., Tschank, G., Seipke, G., Habermann, P., Kurrle, R., & Tennagels, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009540 · Cited by 150 · see citing works
p53 and metabolism: from mechanism to therapeutics
Simabuco, F. M., Morale, M. G., Pavan, I. C. B., Morelli, A. P., Silva, F. R., & Tamura, R. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25267 · Cited by 152 · see citing works
Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women
Rajpathak, S. N., He, M., Sun, Q., Kaplan, R. C., Muzumdar, R. H., Rohan, T. E., Gunter, M. J., Pollak, M., Kim, M., Pessin, J. E., et al. (2012) · Diabetes · doi:10.2337/db11-1488 · Cited by 148 · see citing works
Trichothecene toxicity in eukaryotes: Cellular and molecular mechanisms in plants and animals
Arunachalam, C., & Doohan, F. M. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.12.003 · Cited by 149 · see citing works
Regulation of GH and GH Signaling by Nutrients
Caputo, M., Pigni, S., Agosti, E., Daffara, T., Ferrero, A., Filigheddu, N., & Prodam, F. (2021) · Cells · doi:10.3390/cells10061376 · Cited by 142 · see citing works
Chen, W., Hoo, R. L. C., Konishi, M., Itoh, N., Lee, P.-C., Ye, H., Lam, K. S. L., & Xu, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285965 · Cited by 141 · see citing works
Peng, W., Liu, C., Chen, D., Duan, X., & Zhong, L. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113221 · Cited by 138 · see citing works
Hellström, A., Ley, D., Pupp, I. H., Hallberg, B., Ramenghi, L. A., Löfqvist, C., Smith, L. E. H., & Hård, A. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1586109 · Cited by 126 · see citing works
Werner, H. (2011) · Oncogene · doi:10.1038/onc.2011.447 · Cited by 127 · see citing works
The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus
Ahmed, S. A. H., Ansari, S. A., Mensah‐Brown, E. P. K., & Emerald, B. S. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00896-4 · Cited by 126 · see citing works
Diabetes, insulin, and development of acute lung injury
Honiden, S., & Gong, M. N. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a0fea5 · Cited by 122 · see citing works
Insulin-Like Growth Factor 1 Physiology
Yakar, S., & Adamo, M. L. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.008 · Cited by 123 · see citing works
Self-citationInteraction of the endocrine system with inflammation: a function of energy and volume regulation
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4484 · Cited by 121 · see citing works
“Concerning effects of IGF-1 and growth hormone on metabolism, IGF-1 often demonstrates opposite effects to growth hormone [57].”
BackgroundInfluentialInsulin‐like growth factor‐1 stimulates regulatory T cells and suppresses autoimmune disease
Bilbao, D., Luciani, L., Jóhannesson, B., Piszczek, A., & Rosenthal, N. A. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303376 · Cited by 120 · see citing works
Minireview: mechanisms of growth hormone-mediated gene regulation.
Chia, D. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1099 · Cited by 113 · see citing works
Hinrichs, A., Kessler, B., Kurome, M., Blutke, A., Kemter, E., Bernau, M., Scholz, A. M., Rathkolb, B., Renner, S., Bultmann, S., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.006 · Cited by 115 · see citing works
Stefan, N., Häring, H., Hu, F., & Schulze, M. (2016) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(15)00474-x · Cited by 108 · see citing works
One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology
Argente, J., Chowen, J. A., Jurado, L. A. P., Frystyk, J., & Oxvig, C. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707950 · Cited by 110 · see citing works
Chu, Y.-W., Schmitz, S., Choudhury, B., Telford, W., Kapoor, V., Garfield, S., Howe, D., & Gress, R. E. (2008) · Blood · doi:10.1182/blood-2008-04-149435 · Cited by 107 · see citing works
Gunawardana, S. C., & Piston, D. W. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00570.2014 · Cited by 104 · see citing works
Severe insulin resistance syndromes
Angelidi, A. M., Filippaios, A., & Mantzoros, C. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142245 · Cited by 108 · see citing works
Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21
Guridi, M., Tintignac, L. A. J., Lin, S., Kupr, B., Castets, P., & Rüegg, M. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab3715 · Cited by 99 · see citing works
Regan, S. L. P., Knight, P. G., Yovich, J. L., Arfuso, F., & Dharmarajan, A. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.08.018 · Cited by 98 · see citing works
Insulin-like growth factor-binding protein-6 and cancer
Bach, L. A., Fu, P., & Yang, Z. (2012) · Clinical Science · doi:10.1042/cs20120343 · Cited by 97 · see citing works
Cevenini, A., Orrù, S., Mancini, A., Alfieri, A., Buono, P., & Imperlini, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082411 · Cited by 96 · see citing works
Longevity effect of IGF ‐1 R +/− mutation depends on genetic background‐specific receptor activation
Xu, J., Gontier, G., Chaker, Z., Lacube, P., Dupont, J., & Holzenberger, M. (2013) · Aging Cell · doi:10.1111/acel.12145 · Cited by 93 · see citing works
Growth hormone and prolactin regulate human neural stem cell regenerative activity
Pathipati, P., Gorba, T., Scheepens, A., Goffin, V., Sun, Y., & Fraser, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.029 · Cited by 93 · see citing works
Amuzie, C. J., & Pestka, J. J. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp225 · Cited by 92 · see citing works
Suvorov, A., Battista, M., & Takser, L. (2009) · Toxicology · doi:10.1016/j.tox.2009.03.018 · Cited by 87 · see citing works
Insulin and Growth Hormone Balance: Implications for Obesity
Huang, Z., Huang, L., Waters, M. J., & Chen, C. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.04.005 · Cited by 86 · see citing works
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting Approaches
Bruchim, I., Sarfstein, R., & Werner, H. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00076 · Cited by 86 · see citing works
Peplow, P. V., & Baxter, G. D. (2012) · Photomedicine and Laser Surgery · doi:10.1089/pho.2012.3312 · Cited by 83 · see citing works
The role of insulin-like growth factor-1 in bone remodeling: A review
Fang, J., Zhang, X., Chen, X., Wang, Z., Zheng, S., Cheng, Y., Liu, S., & Hao, L. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124125 · Cited by 81 · see citing works
Watkins, D. J., Peterson, K. E., Ferguson, K. K., Mercado‐García, A., Tamayo‐Ortiz, M., Cantoral, A., Meeker, J. D., & Téllez‐Rojo, M. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2706 · Cited by 79 · see citing works
Disorders of growth hormone/insulin-like growth factor secretion and action
Backeljauw, P. F., Dattani, M., Cohen, P., & Rosenfeld, R. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00019-6 · Cited by 79 · see citing works
So, W. Y., Cheng, Q., Xu, A., Lam, K. S. L., & Leung, P. S. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.80 · Cited by 78 · see citing works
Matsumoto, R., Fukuoka, H., Iguchi, G., Nishizawa, H., Bando, H., Suda, K., Takahashi, M., & Takahashi, Y. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.07.002 · Cited by 78 · see citing works
de Laat, M. A., Pollitt, C. C., Kyaw-Tanner, M. T., McGowan, C. M., & Sillence, M. N. (2013) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.12.026 · Cited by 75 · see citing works
Hofmann, M., Halper, B., Oesen, S., Franzke, B., Stuparits, P., Tschan, H., Bachl, N., Strasser, E.-M., Quittan, M., Ploder, M., et al. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.02.008 · Cited by 74 · see citing works
Rodrı́guez, S., Gaunt, T. R., & Day, I. N. M. (2007) · Human Genetics · doi:10.1007/s00439-007-0378-3 · Cited by 72 · see citing works
Hwang, J., Sim, X., Wu, Y., Liang, J., Tabara, Y., Hu, C., Hara, K., Tam, C. H. T., Cai, Q., Zhao, Q., et al. (2014) · Diabetes · doi:10.2337/db14-0563 · Cited by 70 · see citing works
Payab, M., Abedi, M., Heravani, N. F., Hadavandkhani, M., Arabi, M., Tayanloo-Beik, A., Hosseini, M. S., Gerami, H., Khatami, F., Larijani, B. A., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0616-5 · Cited by 68 · see citing works
Macrophage and adipocyte IGF 1 maintain adipose tissue homeostasis during metabolic stresses
Chang, H. R., Kim, H. J., Xu, X., & Ferrante, A. W. (2015) · Obesity · doi:10.1002/oby.21354 · Cited by 69 · see citing works
Targeting IGF-1 signaling pathways in gynecologic malignancies
Bruchim, I., & Werner, H. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.749863 · Cited by 67 · see citing works
Miao, J., Zhang, Y., Chen, S., Zheng, Q., & Guo, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04457-1 · Cited by 66 · see citing works
Effects of medical therapies for acromegaly on glucose metabolism
Urbani, C., Sardella, C., Calevro, A., Rossi, G., Scattina, I., Lombardi, M., Lupi, I., Manetti, L., Martino, E., & Bogazzi, F. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0032 · Cited by 67 · see citing works
Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1 action
Nagaraj, K., Lapkina-Gendler, L., Sarfstein, R., Gurwitz, D., Pasmanik‐Chor, M., Laron, Z., Yakar, S., & Werner, H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715930115 · Cited by 63 · see citing works
Self-citationWittenbecher, C., Kuxhaus, O., Boeing, H., Stefan, N., & Schulze, M. B. (2019) · Diabetologia · doi:10.1007/s00125-019-04978-8 · Cited by 62 · see citing works
Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy
Werner, H., Sarfstein, R., & Bruchim, I. (2019) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1694660 · Cited by 62 · see citing works
Molecular and functional characterization of two distinct IGF binding protein-6 genes in zebrafish
Wang, X., Lü, L., Li, Y., Li, M., Chen, C., Feng, Q., Zhang, C., & Duan, C. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90969.2008 · Cited by 61 · see citing works
IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
Hellström, A., Ley, D., Hallberg, B., Löfqvist, C., Pupp, I. H., Ramenghi, L. A., Borg, J., Smith, L. E. H., & Hård, A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666171002114545 · Cited by 60 · see citing works
LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice
Touvier, T., Conte-Auriol, F., Briand, O., Cudejko, C., Paumelle, R., Caron, S., Baugé, E., Rouillé, Y., Salles, J., Staels, B., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci34997 · Cited by 59 · see citing works
Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
Werner, H., Sarfstein, R., LeRoith, D., & Bruchim, I. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00159 · Cited by 59 · see citing works
Self-citationLien, Y., Zhang, Z., Cheng, Y., Polyák, E., Sillers, L., Falk, M. J., Ischiropoulos, H., Parry, S. I., & Simmons, R. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157899 · Cited by 56 · see citing works
The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency
Sprogøe, K., Mortensen, E., Karpf, D. B., & Leff, J. A. (2017) · Endocrine Connections · doi:10.1530/ec-17-0203 · Cited by 57 · see citing works
Regan, F. M., Williams, R. M., McDonald, A. L., Umpleby, A. M., Acerini, C. L., O’Rahilly, S., Hovorka, R., Semple, R. K., & Dunger, D. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2088 · Cited by 56 · see citing works
Gu, H. F., Gu, T., Hilding, A., Zhu, Y., Kärvestedt, L., Östenson, C., Lai, M., Kutsukake, M., Frystyk, J., Tamura, K., et al. (2013) · Clinical Epigenetics · doi:10.1186/1868-7083-5-20 · Cited by 56 · see citing works
Backeljauw, P. F., Kuntze, J., Frane, J. W., Calikoglu, A. S., & Chernausek, S. D. (2013) · Hormone Research in Paediatrics · doi:10.1159/000351958 · Cited by 51 · see citing works
Overall Mortality in Diabetes Mellitus: Where Do We Stand Today?
DAILEY, G. E. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0019 · Cited by 51 · see citing works
Sciacca, L., Moli, R. L., & Vigneri, R. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00021 · Cited by 52 · see citing works
Su, W., Lee, K., Yeh, Y., Soon, M., Wang, C., Yu, M., & Wang, S. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20320 · Cited by 50 · see citing works
Mulyani, A. T., Khairinisa, M. A., Khatib, A., & Chaerunisaa, A. Y. (2025) · Nutrients · doi:10.3390/nu17091493 · Cited by 48 · see citing works
Estrogens Regulate the Hepatic Effects of Growth Hormone, a Hormonal Interplay with Multiple Fates
Fernández‐Pérez, L., Guerra, B., Díaz-Chico, J. C., & Flores‐Morales, A. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00066 · Cited by 47 · see citing works
Clinical assays for quantitation of insulin-like-growth-factor-1 (IGF1)
Ketha, H., & Singh, R. J. (2015) · Methods · doi:10.1016/j.ymeth.2015.04.029 · Cited by 47 · see citing works
Metabolic alterations in paediatric GH deficiency
Rothermel, J., & Reinehr, T. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.11.004 · Cited by 48 · see citing works
Teprotumumab-Related Adverse Events in Thyroid Eye Disease
Shah, S., Amarikwa, L., Sears, C. M., Clauss, K. D., Rajjoub, R. D., Kang, J. Y., Tamhankar, M. A., Briceño, C. A., Harrison, A. R., Dosiou, C., et al. (2023) · Ophthalmology · doi:10.1016/j.ophtha.2023.10.018 · Cited by 47 · see citing works
Thankamony, A., Capalbo, D., Marcovecchio, M., Sleigh, A., Jørgensen, S. W., Hill, N., Mooslehner, K., Yeo, G., Bluck, L., Juul, A., et al. (2014) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2013-4542 · Cited by 45 · see citing works
Insulin-like growth factor-I in wound healing of rat skin
Todorović, V., Peško, P. M., Micev, M. T., Bjelović, M., Budeč, M., Mićić, M., Brasanac, D. C., & Ilić-Stojanović, O. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.05.006 · Cited by 45 · see citing works
López-Márquez, A., Carrasco-López, C., Fernández-Méndez, C., & Santisteban, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.654569 · Cited by 49 · see citing works
Eye on the horizon: The metabolic landscape of the RPE in aging and disease
Hansman, D., Du, J., Casson, R. J., & Peet, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101306 · Cited by 48 · see citing works
Cianfarani, S., Inzaghi, E., Alisi, A., Germani, D., Puglianiello, A., & Nobili, V. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.052 · Cited by 43 · see citing works
Jia, T., Axelsson, T. G., Heimbürger, O., Barany, P. F., Lindholm, B., Stenvinkel, P., & Qureshi, A. R. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02470213 · Cited by 43 · see citing works
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
Werner, H., Lapkina-Gendler, L., Achlaug, L., Nagaraj, K., Somri, L., Yaron-Saminsky, D., Pasmanik‐Chor, M., Sarfstein, R., Laron, Z., & Yakar, S. (2019) · Cells · doi:10.3390/cells8060596 · Cited by 41 · see citing works
Self-citationAl-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 42 · see citing works
Higashi, S., Iseki, E., Minegishi, M., Togo, T., Kabuta, T., & Wada, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06930.x · Cited by 41 · see citing works
In Vitro and In Vivo Effects of IGF-1 Delivery Strategies on Tendon Healing: A Review
Miescher, I., Rieber, J., Calcagni, M., & Buschmann, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032370 · Cited by 40 · see citing works
- Authors
- LeRoith, D., & Yakar, S.
- Affiliations
- Mount Sinai Hospital (US)
- Corresponding author
- LeRoith, Derek
- ORCID
- Yakar, Shoshana
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2007-03
- Volume
- 3
- Issue
- 3
- Pages
- 302-310
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W2084967524
- Cited by
- 344
- References
- 71
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 21 · 2023: 18 · 2022: 20 · 2021: 17 · 2020: 25 · 2019: 20 · 2018: 21 · 2017: 14 · 2016: 19 · 2015: 17 · 2014: 22 · 2013: 15 · 2012: 24
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Keywords
- insulin-like growth factor I, growth hormone, IGF-1 receptor, insulin receptor, receptor heterodimerization, tyrosine kinase signaling, insulin-like growth factor II, insulin resistance, hyperglycemia, glucose metabolism, lipid metabolism, protein metabolism, diabetes treatment
- MeSH terms
- Animals, Humans, Insulin-Like Growth Factor I, Models, Biological, Growth Hormone, Models, Animal, Growth and Development, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review